Does Neoadjuvant Chemotherapy Impact Prognosis in Advanced-Stage Epithelial Ovarian Cancer Optimally Debulked at Surgery?

Does Neoadjuvant Chemotherapy Impact Prognosis in Advanced-Stage Epithelial Ovarian Cancer Optimally Debulked at Surgery?

Neoadjuvant chemotherapy (NAC) has been shown to be noninferior to primary surgery in advanced stage ovarian cancer. We examined the impact of the neoadjuvant approach in patients with optimal residuals (

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of obstetrics and gynaecology Canada 2019-02, Vol.41 (2), p.185-190
Hauptverfasser: Al Mutairi, Nashmia, Le, Tien
Format: Artikel
Sprache:eng
Schlagworte:
neoadjuvant chemotherapy
optimal residuals
Ovarian cancer
primary surgery
survival
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Neoadjuvant chemotherapy (NAC) has been shown to be noninferior to primary surgery in advanced stage ovarian cancer. We examined the impact of the neoadjuvant approach in patients with optimal residuals (
ISSN:1701-2163
DOI:10.1016/j.jogc.2018.05.031